NasdaqCM - Delayed Quote USD

ProMIS Neurosciences, Inc. (PMN)

Compare
0.8941
+0.0102
+(1.15%)
At close: January 29 at 4:00:00 PM EST
0.9100
+0.02
+(1.78%)
After hours: 7:01:26 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
1.2273
Operating Expense
14,699.6700
--
23,379.9120
8,291.0930
4,441.9359
Operating Income
-14,699.6700
--
-23,379.9120
-8,291.0930
-4,440.7086
Net Non Operating Interest Income Expense
-153.5700
--
-282.0640
-416.2860
0.1741
Other Income Expense
14,289.8910
--
5,599.7130
-1,082.7270
--
Pretax Income
-563.3490
--
-18,062.2630
-9,790.1060
-4,440.5345
Net Income Common Stockholders
-563.3490
--
-18,062.2630
-9,790.1060
-4,440.5345
Diluted NI Available to Com Stockholders
-563.3490
--
-18,062.2630
-9,790.1060
-4,440.5345
Basic EPS
0.04
-1.07
-2.41
-1.69
-0.94
Diluted EPS
0.04
-1.07
-2.41
-1.69
-0.94
Basic Average Shares
22,111.7310
12,292.7070
7,502.6090
5,785.6170
4,759.9970
Diluted Average Shares
22,653.4960
12,292.7070
7,502.6090
5,785.6170
4,759.9970
Total Operating Income as Reported
-14,699.6700
--
-23,379.9120
-8,291.0930
-4,440.5345
Total Expenses
14,699.6700
--
23,379.9120
8,291.0930
4,441.9359
Net Income from Continuing & Discontinued Operation
-563.3490
--
-18,062.2630
-9,790.1060
-4,440.5345
Normalized Income
-14,266.0630
--
-23,546.4510
-8,694.4700
-4,440.5345
Interest Income
--
--
--
4.7317
0.1741
Interest Expense
153.5700
--
282.0640
416.2860
--
Net Interest Income
-153.5700
--
-282.0640
-416.2860
0.1741
EBIT
-409.7790
--
-17,780.1990
-9,373.8200
-4,440.5345
EBITDA
-391.7580
--
-17,768.9830
-9,327.9950
-4,428.2004
Reconciled Depreciation
18.0210
--
11.2160
45.8250
12.3341
Net Income from Continuing Operation Net Minority Interest
-563.3490
--
-18,062.2630
-9,790.1060
-4,440.5345
Total Unusual Items Excluding Goodwill
13,702.7140
--
5,484.1880
-1,095.6360
--
Total Unusual Items
13,702.7140
--
5,484.1880
-1,095.6360
--
Normalized EBITDA
-14,094.4720
--
-23,253.1710
-8,232.3590
-4,428.2004
12/31/2020 - 1/10/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

115450.KQ HLB Therapeutics Co.,Ltd.
11,340.00
-2.91%
 
TGRP TRON Group Inc.
0.0380
-23.69%
 
ZHCLF Zenith Capital Corp.
0.0001
0.00%
 
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
 
ANL Adlai Nortye Ltd.
2.0500
-1.91%
 
IVA Inventiva S.A.
2.3000
+0.88%
 
PHGE BiomX Inc.
0.7692
-1.40%
 
APS.TO Aptose Biosciences Inc.
0.2550
-5.56%
 
SCNI Scinai Immunotherapeutics Ltd.
3.5346
-1.82%
 
NBTX Nanobiotix S.A.
3.4600
+3.59%